– The most important prognostic factors in renal carcinoma are the stage and grade. World literature is full of information on new markers, the analysis of DNA with the cytofluorimetric method being foremost, as it allows the cell lines in the neoplasm to be assessed and at the same time the ploidy and cell cycle stages to be studied. We have found an excellent correlation between the ploidy and cell grade. After a preliminary study we can conclude that the method is easy to perform and to reproduce. The procedure is also interesting for retrospective studies which allow the pathologist to select the blocks to be examined, thereby avoiding those widely contaminated by hemorrhages or necrosis.
Mc NicholsD.W., SeguraJ.W., De WurdJ.H.: Renal cell carcinoma: long term survival and rate recurrence. J. Urol., 126: 17–23, 1981.
2.
SelliC., HiushawW.H., WoodardB.N., PaulsonD.F.: Stratification of risk factors in renal cell carcinoma. Cancer, 52: 899–903, 1983.
3.
SkinnerD.G., VermillianC.D., CalvinR.B.: The surgical management of renal cell carcinoma. J. Urol., 107: 705–710, 1972.
4.
SurjanenK., HijeltL.: Grading of human renal adenocarcinoma. Scand. J. Urol. Nephrol., 12: 49–55, 1978.
5.
PeterS.: Oncogenes and growth factors in renal cell carcinoma. Urol. Int., 47: 199–202, 1991.
6.
De RieseW., CrabtruW.N., AllohoffE.P., WernerM., LiedkeS., LenisG., AtzpodienJ., KirchnerH.: Prognostic significance of Ki-67 immunostaining in non metastatic renal cell carcinoma. J. of Clin. Oncol., 11 (9): 1804–1808, 1993.
7.
ChiosholmG.D.: Oncogenes and molecular genetics of renal tumours. In: OlssonC.A.: Oncogenes and molecular genetics of urological tumours. Churchill Livingstone, Edinburg, 15–22, 1992.
8.
GuF.L., ShenJ.C., ZhouA.R., GeZ.L.: Amplification and expression of the c-erbB-2/neu and c-myc proto-oncogenes in bladder cancer and renal cell carcinoma. In: OlssonC.A.: Oncogenes and molecular genetics of urological tumours. Churchill Livingstone, Edinburg, 103–109, 1992.
9.
YaoM., ShuinT., MisakiH.: Enhanced expression of c-myc and epidermal growth factor receptor (c-erbB1) genes in primary human renal cancer. Cancer Res., 48: 6753–6757, 1988.
10.
DelahuntB., BethwaiteP.B., NaceyJ.N., RibasJ.L.: Proliferating cell nuclear antigen (pcna)expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index and silverstaining nucleolar organizer region numbers. J. Pathol., 170: 471–477, 1993.
11.
HedleyD.W., FriedlanderM.L., TaylorI.W.: Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploid and its clinical significance. Cytometry, 6: 327, 1985.
12.
BaischH., OttoU., KloppelG.: Malignancy index based on flow cytometry and histology for renal cell carcinoma and its correlation to prognosis. Cytometry, 7: 200, 1986.
13.
OttoU., BaischH., HulandH., KloppelG.: Tumour cell deoxyribonucleic acid content and prognosis in human renal cell carcinoma. J. Urol., 132: 237, 1984.
14.
RainwaterL.M., HosakaY., FarrowG.M., LieberM.M.: Well differentiated clear cell renal carcinoma: significance of nuclear deoxyribonucleic acid patterns studied by flow cytometry. J. Urol., 137: 15, 1987.
15.
GrignonD.J., El-NaggarA., GreenL.K., AyalaA. G., RoJ.Y., SwansonD.A., TroncosaP., McLemoreD., GiaccoG.G., GuineeV.F.: DNA flow cytometry as a predictor of outcome of stage 1 renal cell carcinoma. Cancer, 63: 1161, 1989.
16.
DeKernionJ.B., MukamelE., RitchieA.W.S., BlytB., HannahJ., BohomanR.: Prognostic significance of the DNA content of renal carcinoma. Cancer, 64: 1669, 1989.
LungbergB., Nordenson., RoosG.: Cytogenetic and flow cytometryc DNA analysis in renal cell carcinoma. Eur. Urol., 19: 59, 1991.
19.
ChinJ.L., PontesJ.E., FrankfurtO.S.: Flow cytometric deoxyribonucleic acid analysis of primary and metastatic human renal cell carcinoma. J. Urol., 133: 582, 1985.
20.
YuD.S., HsuC.M., LeeW.H., ChangS.Y., MaC.P.: Flow cytometric DNA and cytomorphometric analysis in renal cell carcinoma: its correlation with histopathology and prognosis. J. of Surg. Res., 55: 480–485, 1993.
